Latest Company Announcements News

Antipa Minerals has reported multiple new gold and copper discoveries at its Minyari Project in Western Australia, including a high-grade gold lode at Fiama and a significant copper trend at Yolanda. These findings bolster the project's resource base ahead of an updated Mineral Resource Estimate due in February 2026.

Cauldron Energy’s latest groundwater analysis at the Yanrey Uranium Project reveals low chloride and sulphate levels, affirming the site’s suitability for environmentally friendly in situ recovery uranium mining. This milestone supports the company’s plans to expand resources and advance towards production.

EVE Health Group has transitioned from development to commercial rollout, delivering first patient prescriptions of Dyspro™ and completing initial manufacturing of Libbo™, supported by a $1.1 million capital raise.

Aland Equity Group Limited has completed significant capital raisings and board restructuring while navigating a challenging quarter for its flagship Growth Fund. The company is positioning itself for expansion into property funds management.

Audio Pixels has validated a major technical milestone for its digital MEMS speaker array and raised $1.25 million through convertible notes, while securing a $6 million funding commitment to support ongoing development amid continued ASX trading suspension.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

CuFe Ltd has raised $5.4 million through a strategic placement and upgraded its Tennant Creek resource to include valuable critical minerals, setting the stage for a major drilling campaign.

Percheron Therapeutics has reported encouraging safety and efficacy signals from its HMBD-002 phase I trial, and outlined an innovative modular phase II trial design targeting multiple cancers in 2026.

Nanollose has advanced its largest pilot production of Nullarbor™ fibre, integrating a refined microbial cellulose process that promises easier adoption by textile manufacturers. The company also bolstered its intellectual property portfolio and secured additional funding post-quarter.

Battery Age Minerals has completed maiden drilling programs in Austria and Argentina, secured full ownership of its Canadian lithium project, and raised A$5.5 million to fuel its 2026 exploration ambitions.

Inhalerx Limited reported a $628,000 cash burn in the December quarter while securing substantial funding facilities to advance its clinical trials. The company’s cash position and financing arrangements suggest a runway extending over 80 quarters at current spending levels.

Dimerix Limited has completed recruitment for its pivotal ACTION3 Phase 3 trial targeting a rare kidney disease, secured positive FDA feedback on trial endpoints, and reported a solid cash position of AU$38.5 million at the end of 2025.